您的位置: 首页 > 农业专利 > 详情页

Modification of allergens for immunotherapy
专利权人:
HAL Allergy Holding B.V.
发明人:
Luijkx, Dionisius Marinus Antonius Maria,Koppelman, Stefan Johan,Sleijster-Selis, Henriette Emilie,Van Den Hout, Robertus Henricus Joannes Alfonsus
申请号:
AU2009265601
公开号:
AU2009265601B2
申请日:
2009.07.06
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
The present invention relates to pharmaceutical compositions for immunotherapy, for example for immunotherapy of peanut allergy. Further, the present invention relates to methods for the preparation of the present pharmaceutical compositions for immunotherapy, and their use in immunotherapy. Furthermore, the present invention relates to processes for modifying allergens thereby enhancing their application in immunotherapy. The invention also relates to the present modified allergens and pharmaceutical compositions comprising the present allergens, as well as to the use thereof in immunotherapy. According to a particularly preferred embodiment, the present invention relates to pharmaceutical compositions for immunotherapy comprising reduced and alkylated naturally occurring peanut allergens Ara h2 and/or Ara h6, or derivates or isoforms thereof wherein said pharmaceutical composition substantially does not comprise Ara h1 and/or Ara h3.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充